GERD (acid reflux) decisions — 2025

The Board denied an initial rating in excess of 10 percent for GERD, finding that the Veteran's symptoms did not meet the criteria for a higher rating.

The Board granted a 50 percent disability rating for tension headaches but denied an increased rating greater than 10 percent for scars, lower left extremity, left ankle and left heel. The claim for a disability rating greater than 10 percent for GERD was remanded.

The Board remands the claims for service connection and increased rating as they require further development, including new examinations.

The Veteran withdrew appeals for service connection of multiple conditions, resulting in the dismissal of all claims.

The Board remands the claims for an initial rating in excess of 10 percent for GERD and a compensable rating for migraines with migraine variants due to deficiencies in the VA examinations.

The Board denied a rating in excess of 30 percent for GERD from January 23, 2013 to October 18, 2023 and granted a disability rating of 60 percent for the period beginning on October 18, 2023.

The Board remands the claim for an increased rating in excess of 10 percent for a digestive system disability, characterized as GERD with Barrett's esophagus, due to an inadequate VA examination.

The Board dismissed the appeal for an earlier effective date for Dependents' Educational Assistance and denied a higher initial rating for gastroesophageal reflux disease.

The Veteran's service-connected migraine headaches have prevented her from being able to secure and follow substantially gainful occupation, and she is granted a total disability rating based on individual unemployability (TDIU) and special monthly compensation (SMC) at the statutory housebound rate.

The Board granted service connection for lumbosacral strain and degenerative arthritis of the spine, GERD as secondary to panic disorder and sleep apnea, and migraine headaches as secondary to panic disorder and erectile dysfunction. The effective date for asthma was denied earlier than November 28, 2016.

The Veteran was granted an effective date of December 19, 1996, for the award of a separate rating for insomnia and a 50 percent rating from May 3, 2024, for his insomnia.

The Board granted an earlier effective date for diabetes mellitus type II and service connection for GERD, while denying increased ratings for lung cancer, hypertension, and hearing loss, among other issues.

The Board denied the veteran's claims for an earlier effective date for increased ratings for coronary artery disease and gastroesophageal reflux disease, as no factually ascertainable increase in disability occurred within one year prior to the filing of the claim.

The Board denied service connection for gastroesophageal reflux disease (GERD) and headaches as the evidence did not support a finding that these conditions were related to the Veteran's military service.

The Board denied service connection for irritable bowel syndrome, as the evidence did not support a finding that it began during active service or was related to an in-service injury. The claims for GERD and OSA were remanded for further development.

The Board denied an initial rating in excess of 10 percent for gastroesophageal reflux disease (GERD) as the Veteran's symptoms did not result in considerable impairment of health.

The Board remands the claim for service connection for GERD to correct pre-decisional duty to assist errors.

The Board remands the claims for a rating in excess of 10 percent for GERD and service connection for chest pain, fatigue, and shortness of breath due to COVID-19 to correct duty-to-assist errors.

The Board remands the Veteran's claim for a disability evaluation in excess of 10 percent for hiatal hernia and GERD due to insufficient evidence regarding flare-ups, functional loss, and ameliorative effects of medication.

The Board denied service connection for hemorrhoids and remanded claims for service connection for gastroesophageal reflux disease, hypertension, irritable bowel syndrome, and an initial rating in excess of 70 percent for posttraumatic stress disorder.